DOCSLIB.ORG

Poster: Publikace 2008

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Poster: Publikace 2008 Publikované Práce lékařů Šiklova Patologicko – anatomického ústavu a bioPtické laboratoře s.r.o. za rok 2008 Časopisy s „impact“ faktorem syringofibroadenoma associated with well-differentiated squamous cell 28. Kuroda N., Katto K., Yamaguchi T., Kawada T., ImamuraY., Hes O., Michal M., 42. Vazmitel M., Spagnolo D.V., Němcová J., Michal M., Kazakov D.V.: 1. Alvarado-Cabrero I., Perez-Montiel D.M., Hes, O.: Multicystic urothelial carcinoma. Am J Dermatopathol, 30, 572-574, 2008. Shuin T., Lee G.H.: Chromophobe renal cell carcinoma: Diagnostic ancillary Hidradenoma papilliferum with a ductal carcinoma in situ component. Case report and review of the literature. Am J Dermatopathol, 30, 392-394, 2008. carcinoma of the bladder with gland-like lumina and with signet-ring cells. 17. Kacerovska D., Michal M., Kreuzberg B., Mukensnabl P., Kazakov DV.: application of imprint cytology and fluorescencein situ hybridization of Acral calcified vascular leiomyoma of the skin: a rare clinicopathological chromosomes 10 and 21 in two cases of typical and eosinophilic variants. 43. Vazmitel M., Michal M., Kazakov D.V.: Merkel cell carcinoma with a A case report. Diagn Pathol, 3, 36, 2008. follicular lymphocytic infiltrate: report of two cases. Am J Dermatopathol, 2. Beneš Z., Chlumská A., Antoš Z., Kohout P., Sequens R.: Detection of variant of cutaneous vascular leiomyomas: report of 3 cases. J Amer Acad Med Mol Morphol, 41, 227-232, 2008. 29. Kuroda N., Kato K., Tamura M., Shiotsu T., Hes O., Michal M., Hagashima 30, 389-391, 2008. carcinoma by means of endoscopic cytoscopy in the area of ulcerative colitis. Dermatology, 59,1000-1004, 2008. Y., Ohara M., Hirouchi T., Mizuno K., Hayashi Y., Lee GH.: Carcinoid tumor 44. Yang X.J., Zhou M., Hes O., Shen S., Li R., Lopez J., Shah R.B., Yang Y., Scandinavian J Gastroenterol, 43, 895-896, 2008. 18. Kacerovská D., Szepe P., Vaněček T., Němcová J., Michal M., Mukenšnabl of the pelvis. Consideration on the histogenesis. Pathol Int, 58, 51-54, 2008. Chuang S.T., Lin F., Tretiakova M.M., Kort E.J., Teh B.T.: Tubulocystic 3. Belousova I., Němcová J., Kacerovská D., Michal M., Kazakov D.V.: P., Kazakov D V.: Spiradenocylindroma-like basaloid carcinoma of the anus 30. Lasota J., Corless C.L., Heinrich M.C., Debiec-Rychter M., Sciot R., carcinoma of the kidney: clinicopathologic and molecular characterization. Atypical histopathological features in cutaneous lymphoid hyperplasia of the and rectum: case report, including HPV studies and analysis of the CYLD Am J Surg Pathol, 32, 177-187, 2008. Wardelmann E., Merkelbach-Bruse S., Schildhaus H.U., Steigen S.E., scrotum. Am J Dermatopath, 30, 407-408, 2008. gene mutations. Am J Dermatopathol, 30, 472-476, 2008. Stachura J., Wozniak A., Antonescu C., Daum O., Martin J., Del Muro J.G., 4. Belousova I., Vaněček T., Samtsov A.V., Michal M., Kazakov D.V.: 19. Kacerovská D., Michal M., Kazakov D.V.: Sebocyte-like melanocytes in ostatní Časopisy Miettinen M.: Clinicopathologic profile of gastrointestinal stromal tumors A patient with clinicopathologic features of small plaque parapsoriasis desmoplastic blue nevus. Am J Dermatopathol, 30, 509-510, 2008. 1. Belousova I.E., Kazakov D.V., Sosna B., Šulc M., Michal M.: Small-cell (GISTs) with primary KIT exon 13 or exon 17 mutations: a multicenter study presenting later with plaque-stage mycosis fungoides: report of a case and 20. Kazakov D.V., Magro G., Kutzner H., Spagnolo D.V., Yang Y., Zaspa O., variant of CD30+ -anaplastic large-cell lymphoma of the skin Arkh Patol, 70, Mukenšnabl P., Michal M.: Spiradenoma and spiradenocylindroma with on 54 cases. Mod Pathol, 21, 476-484, 2008. 40-43, 2008. comparative retrospective study of 27 cases of “nonprogressive” small plaque 31. Mego M., Sýcová-Milá Z., Rejleková K., Rychlý B., Obertová J., Rajec J., parapsoriasis. J Am Acad Dermatol, 59, 474-482, 2008. an adenomatous or atypical adenomatous component: a clinicopathological 2. Hes O., Hora M.: Význam současné patologické klasifikace uroteliálních lézí study of 6 cases. Am J Dermatopathol, 30, 436-441, 2008. Hes O., Mardiak J.: Sunitinib in the treatment of tubulocystic carcinoma of pro klinickou praxi. Čes Urol, 12, 5-10, 2008. 5. Eret V., Hora M., Sýkora R., Hes O., Ürge T., Klečka J., Matějovič M.: the kidney. A case report. Ann Oncol, 19, 1655-1656, 2008. 21. Kazakov D.V., Belousova I., Kacerovská D., Šíma R., Vaněček T., Vazmitel 3. Hnízdo J., Hes O., Chylíková L., Nágl I., Šmíd B.: Lymfoproliferativní GreenLight (532 nm) Laser Partial Nephrectomy Followed by Suturing of 32. Michal M., Hes O., Kazakov D.V.: Mesothelial glandular structures within M., Pizinger K., Michal M.: Hyperplasia of hair follicles and other adnexal onemocnění u dvou hroznýšů královských spojené s retrovirovou infekcí. Collecting System Without Renal Hilar Clamping in Porcine Model. Urology, pseudosarcomatous proliferative funiculitis-A diagnostic pitfall. Report of 17 Vet Klinika,, 5, 192-197, 2008. structures in cutaneous lymphoproliferative disorders: a study of 53 cases, May 23 [Epub ahead of print], 2008. cases. Int J Surg Pathol, 16, 48-56, 2008. 4. Hora M., Hes O., Eret V., Ürge T., Klečka J., Ferda J., Chudáček Z., Vaněček including so-called pseudolymphomatous folliculitis and overt lymphomas. 6. Ferda J., Ferdová E., Záhlava J., Walter J., Mukenšnabl P., Daum O., 33. Pizinger K., Cetkovská P., Kacerovská D., Kumpová M.: Successful T., Michal M.: Translokační renální karcinom Xp11.2 typu ASPL/TFE3. Am J Surg Pathol 32, 1468-1478, 2008. Kreuzberg B.: (18)F-FDG-PET/CT of orofacial tumors, a value of whole-body treatment of cutaneous leishmaniasis by photodynamic therapy and Čes Urol, 12, 186-193, 2008. imaging approach. Eur J Radiol, 68, Dec 18 [Epub ahead of print], 2008. 22. Kazakov D.V., Calonje E., Vittay G., Michal M.: High-grade trichoblastic cryotherapy. Eur J Dermatol, Dec 23. [Epub ahead of print], 2008. 5. Kinkor Z., Daum O.: Nádor ovaria jako komplikace diagnostiky 7. Gabriel B., Hausen A.Z., Bouda J., Boudová L., Kopřivová M., Hirschfeld carcinosarcoma. Am J Dermatopathol, 30, 60-62, 2008. 34. Reischig T., Jindra P., Hes O., Švecová M., Klaboch J., Třeška V.: extraintestinálního gastrointestinálního stromálního tumoru – dvě kazuistiky. M., Jager M., Stickeler E.: Significance of nuclear hTra2-beta1 expression in 23. Kazakov D.V., Kutzner H., Spagnolo D.V., Kempf W., Zelger B., Valacyclovir prophylaxis versus preemptive valganciclovir therapy to prevent Čes Gynek, 73, 54-57, 2008. cervical cancer. Acta Obstet Gynecol Scand, 3, 1-6, 2008. Mukensnabl P., Michal M.: Sebaceous differentiation in poroid neoplasms: cytomegalovirus disease after renal transplantation. Am J Transplant, 6. Klečka J., Hora M., Ürge T., Hes O.: Benigní mucinózní cystadenom. Čes Urol, 12, 209-213, 2008. 8. Gatalica Z., Lilleberg S.L., Vaněček T., Hes O., Wang B., Michal M.: Cox-2 report of 11 cases, including a case of metaplastic carcinoma 8, 69-77, 2008. 7. Moláček J., Třeška L., Čertík B., Křižan J., Kuntscher V., Novák M., Duras gene polymorphisms and protein expression in renomedullary interstitial cell associated with apocrine poroma (sarcomatoid apocrine 35. Shelekhova K.V., Hejda V., Kazakov D.V., Michal M.: Mature cystic P., Hes O.: Management of the lienal artery aneurysms in the Plzen Surgical tumors. Hum Pathol, 39, 1495-1504, 2008. porocarcinoma). Am J Dermatopathol, 30, 21-23, 2008. teratoma of the ovary with male accessory sexual glands including seminal 9. Hes O., Michal M., Šíma R., Vaněček T., Brunelli M., Martignoni G., 24. Kempf W., Ostheeren-Michaelis S., Paulli M., Lucioni M., Clinic during 2002-2007. Rozhl Chir, 87, 141-144, 2008. vesicles, prostatic tissue and bulbo-urethral glands: a case report. Virchows 8. Shelekhova K.V., Šíma R., Orlov A.I., Kazakov D.V., Michal M.: Intraneural Kuroda N., Alvarado-Cabrero I., Perez-Montiel D.M., Hora M., Ürge T., Wechsler J., Audring H., Assaf C., Rüdiger T., Willemze R., Arch, 452, 109-111, 2008. perineurioma: clinical and morphological characteristics and a molecular Dvořák M., Jarošová M., Yang X.: Renal oncocytoma with and without Meijer C.J., Berti E., Cerroni L., Santucci M., Hallermann 36. Shelekhova K.V., Michal M., Kazakov D.V.: Hybrid neurofibroma- genetic study of the neurofibromatosis type 2 gene. Arkh Patol, intravascular extension into the branches of renal vein have the same C., Berneburg M., Chimenti S., Robson A., Marschalko M., perineurioma: an additional example of an extradigital tumor. Ann Diagn 70, 20-22, 2008. morphological, immunohistochemical, and genetic features. Virchows Arch, Kazakov D.V., Petrella T., Fraitag S., Carlotti A., Courville Pathol, 12, 233-234, 2008. 9. Sutnar A., Skalický T., Třeška V., Hes O., Mírka H., Michal M., Novák P., 452, 285-293, 2008. P., Laeng H., Knobler R., Golling P., Dummer R., Burg 37. Skálová A., Šíma R., Bohuš P., Čuřík R., Lukáš J., Michal M.: Liška V.: Liver cystadenoma with ovarian stroma-a case review. Rozhl Chir, 10. Hes O., Šíma R., Němcová J., Brunelli M., Hora M., Bulimbasic S., G.: Granulomatous mycosis fungoides and granulomatous Endolymphatic sac tumor (Aggressive papillary tumor of middle ear and 87, 259-262, 2008. Kazakov D.V., Ürge T., Reischig T., Dvořák M., Michal M.: End-stage slack skin: a multicenter study of the Cutaneous Lymphoma temporal bone). Report of two cases with analysis of the VHL gene. Pathol 10. Ürge T., Hora M., Hes O., Votavová M., Bulka J., Ferda J., Ferdová E., kidney disease: Gains of chromosomes 7, 17 and loss of Y chromosome in Histopathology Task Force Group of the European Organization Res Pract, 204, 599-606, 2008. Skalický T.: Primitivní neuroektodermální tumor ledviny (PNET). Čes Urol, non-neoplastic tissue. Virchows Arch, 453, 313-319, 2008. For Research and Treatment of Cancer (EORTC). Arch 38. Skálová A., Šíma R., Němcová J., Korabečná M., Walter 12, 44-8, 2008.
Load more

Recommended publications
  • Genitourinary Pathology (Including Renal Tumors)
    LABORATORY INVESTIGATION THE BASIC AND TRANSLATIONAL PATHOLOGY RESEARCH JOURNAL LI VOLUME 99 | SUPPLEMENT 1 | MARCH 2019 2019 ABSTRACTS GENITOURINARY PATHOLOGY (INCLUDING RENAL TUMORS) (776-992) MARCH 16-21, 2019 PLATF OR M & 2 01 9 ABSTRACTS P OSTER PRESENTATI ONS EDUCATI ON C O M MITTEE Jason L. Hornick , C h air Ja mes R. Cook R h o n d a K. Y a nti s s, Chair, Abstract Revie w Board S ar a h M. Dr y and Assign ment Co m mittee Willi a m C. F a q ui n Laura W. La mps , Chair, C ME Subco m mittee C ar ol F. F ar v er St e v e n D. Billi n g s , Interactive Microscopy Subco m mittee Y uri F e d ori w Shree G. Shar ma , Infor matics Subco m mittee Meera R. Ha meed R aj a R. S e et h al a , Short Course Coordinator Mi c h ell e S. Hir s c h Il a n W ei nr e b , Subco m mittee for Unique Live Course Offerings Laksh mi Priya Kunju D a vi d B. K a mi n s k y ( Ex- Of ici o) A n n a M ari e M ulli g a n Aleodor ( Doru) Andea Ri s h P ai Zubair Baloch Vi nita Parkas h Olca Bast urk A nil P ar w a ni Gregory R. Bean , Pat h ol o gist-i n- Trai ni n g D e e p a P atil D a ni el J.
    [Show full text]
  • Analysis of the Clinical Relevance of Histological Classification of Benign Epithelial Salivary Gland Tumours
    Analysis of the Clinical Relevance of Histological Classification of Benign Epithelial Salivary Gland Tumours Hellquist, Henrik; Paiva-Correia, António; Vander Poorten, Vincent; Quer, Miquel; Hernandez- Prera, Juan C; Andreasen, Simon; Zbären, Peter; Skalova, Alena; Rinaldo, Alessandra; Ferlito, Alfio Published in: Advances in Therapy DOI: 10.1007/s12325-019-01007-3 Publication date: 2019 Document version Publisher's PDF, also known as Version of record Document license: CC BY-NC Citation for published version (APA): Hellquist, H., Paiva-Correia, A., Vander Poorten, V., Quer, M., Hernandez-Prera, J. C., Andreasen, S., Zbären, P., Skalova, A., Rinaldo, A., & Ferlito, A. (2019). Analysis of the Clinical Relevance of Histological Classification of Benign Epithelial Salivary Gland Tumours. Advances in Therapy, 36(8), 1950-1974. https://doi.org/10.1007/s12325-019-01007-3 Download date: 01. okt.. 2021 Adv Ther (2019) 36:1950–1974 https://doi.org/10.1007/s12325-019-01007-3 ORIGINAL RESEARCH Analysis of the Clinical Relevance of Histological Classification of Benign Epithelial Salivary Gland Tumours Henrik Hellquist . Anto´nio Paiva-Correia . Vincent Vander Poorten . Miquel Quer . Juan C. Hernandez-Prera . Simon Andreasen . Peter Zba¨ren . Alena Skalova . Alessandra Rinaldo . Alfio Ferlito Received: May 2, 2019 / Published online: June 17, 2019 Ó The Author(s) 2019 ABSTRACT to investigate whether an accurate histological diagnosis of the 11 different types of benign Introduction: A vast increase in knowledge of epithelial salivary gland tumours is correlated to numerous aspects of malignant salivary gland any differences in their clinical behaviour. tumours has emerged during the last decade Methods: A search was performed for histolog- and, for several reasons, this has not been the ical classifications, recurrence rates and risks for case in benign epithelial salivary gland malignant transformation, treatment modali- tumours.
    [Show full text]
  • A034047-100 Top Secrets.Qxd 5/18/06 2:32 PM Page 1
    A034047-100 Top Secrets.qxd 5/18/06 2:32 PM Page 1 TOP 100 SECRETS These secrets are 100 of the top board alerts. They summarize the concepts, principles, and most salient details of CT body scans. 1. Computed tomography (CT) differs from conventional radiography by forming a cross-sectional image, eliminating the superimposition of structures that occurs in plain film imaging because of compression of three-dimensional body structures onto the two-dimensional recording system. 2. The sensitivity of CT to subtle differences in x-ray attenuation is at least a factor of 10 higher than normally achieved by film screen recording systems because of the virtual elimination of scatter. 3. Radiation doses in CT range from 15–50 mGy, depending on exam type. In general, these doses are at least 10 times higher than in radiographic exams. 4. Always seek to optimize scan parameters to minimize patient dose consistent with diagnostic image quality: Minimize mAs, minimize kVp, maximize pitch, maximize slice thickness, and maximize collimator setting. 5. When scanning children, be sure to use pediatric protocols, not adult protocols. In pediatric protocols the CT scan parameters should be reduced so that radiation doses are optimized according to patient size. 6. Pregnant women should be scanned only if there is adequate justification to avoid unnecessary fetal irradiation. 7. Many of the side effects of contrast media are entirely or mainly due to high osmolality. The other causes of side effects due to contrast media are chemotoxicity (allergic-like symptoms), ion toxicity (interference with cellular function), and those caused by a high dose.
    [Show full text]
  • Title Acta Urologica Japonica Vol. 35, 1989 Author(S)
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Kyoto University Research Information Repository Title Acta Urologica Japonica Vol. 35, 1989 Author(s) Citation 泌尿器科紀要 (1989), 35(12): xii-xxvii Issue Date 1989-12 URL http://hdl.handle.net/2433/116762 Right Type Others Textversion publisher Kyoto University xll Acta Urologica Japonica Vol. 35, 1989 Vol. 35, No. 1January 1989 Study on Urinary (3-Glucuronidaseand Alkaline Phosphatase Activities as Indicators of CDDP Renal Toxicity ...............T. Takahashi et al.••• I Transurethral Ureterolithotripsy under Hydraulic Ureteral Dilatation .................................................................................Y. Mori et al.••• 7 Significanceof Isoantigen in the Managemantof the Urinary Bladder Tumor —A Basic Study of ABO Isoantigen in Step Sections of Entire Bladder—.................................................................................T. Ogawa et al.••• 13 An Experimental Study on Bladder Carcinogenesisin Dogs by N-Butyl-N-(4-Hydroxybutyl)Nitrosamine (BBN) and its Urinary Metabolites ............................................................S. Morishita et al.••• 27 A New Clinical Trial Intravesical Chemotherapywith Instillation of Peplomycin Preparation Emulsion in Hydroxypropylcellulosum —PreliminaryStudy of Patients with Bladder Tumor—.........M. Asakawa et al.••• 39 Studies of the New Parameter Based Urinary Flow Rate Curve in Benign Prostatic Hypertrophy ......................................................C. Haraguchi•••
    [Show full text]
  • Comprehensive Inherited Cancer Precision Panel Overview
    Comprehensive Inherited Cancer Precision Panel Overview Hereditary cancer syndromes are encountered in all medical specialties. Although they account for about 5% of all malignancies, it is of special importance to identify these patients because, unlike patients with sporadic cancers, they require special, long-term care as their predisposition can cause them to develop certain tumors at a relatively early age. These cancers can arise in the lungs, kidneys, liver, pancreas, skin, eyes, heart. Most hereditary cancers are associated with a “germline mutation” that will be present in every cell of the human body. Identification of patients at risk of inherited cancer susceptibility is dependent upon the ability to characterize genes and alterations associated with increased cancer risk as well as gathering a detailed personal and family history aiding in the identification of the mode of inheritance as well as other family members at risk of suffering from this susceptibility. Most hereditary cancer syndromes follow an autosomal dominant inheritance, and the penetrance is high. The Igenomix Comprehensive Inherited Cancer Precision Panel provides a comprehensive analysis of the most common hereditary cancer syndromes using next-generation sequencing (NGS) to fully understand the spectrum of relevant cancer predisposition genes. Indications The Igenomix Comprehensive Inherited Caner Precision Panel is indicated as a screening and diagnostic test in those cases where there are: ‐ Multiple relatives on the same side of the family with the same or related forms of cancer ‐ Cancer at an early age ‐ Early presentation of an aggressive cancer type ‐ Multiple primary cancers in an individual 1 Clinical Utility The clinical utility of this panel is: ‐ Early and accurate genetic diagnosis allowing the most appropriate clinical management of a patient with personal or family history suggestive of a hereditary cancer syndrome.
    [Show full text]
  • Q35;Ql3) Breakpoint
    PDF hosted at the Radboud Repository of the Radboud University Nijmegen The following full text is a publisher's version. For additional information about this publication click this link. http://hdl.handle.net/2066/25861 Please be advised that this information was generated on 2021-09-25 and may be subject to change. ELSEVIER Fine Mapping of the Human Renal Oncocytoma- Associated Translocation (5;ll)(q35;ql3) Breakpoint Richard J. Sinke, Trynie Dijkhuizen, Bert Janssen, Daniël Olde Weghuis, Gérard Merkx, Eva van den Berg, Ed Schuuring, Aurelia M. Meloni, Bauke de Jong, and Ad Geurts van Kessel ABSTRACT: Recent cytogenetic analysis of a series of human renal oncocytomas revealed the presence of a recurring chromosomal translocation (5;ll)(q35;ql3) as sole anomaly in a subset of the tumors. The molecular characterization of this translocation was initiated using two primary t(5;ll)-positive renal oncocytomas and a panel of soma tic cell hybrids derived from one of these tumors, in conjunction with fluorescence in situ hybridization (FISH) and Southern blot analysis. The breakpoint in chromosome band llql3 could be located within a genomic interval of at maximum 400 Kb immediately centromeric to the BCLl locus. © Elsevier Science Inc., 1997 INTRODUCTION cytogenetic anomaly in at least 3 independent cases and, as such, should be considered as a primary change. Deletion of Oncocytomas are benign tumors that occur predominantly 3p material that occurs in the majority of renal cell carci­ in the kidney, accounting for approximately 5% of all pri­ nomas [16,17] has not been observed in renal oncocytomas. mary tumors at that site.
    [Show full text]
  • 2015 DQC Review of Answers
    Question 1 A 55-year-old gentleman is referred for Mohs surgery of a biopsy positive metatypical basal cell carcinoma of the R lateral forehead. Based on the findings on this slide what additional tests would you consider? A. Send tissue for CK 20 staining. B. Order a CT to look for pulmonary changes/renal oncocytoma. C. Send tissue for MLH-1, and MSH-2 and 6 staining. D. Check thyroid function tests. Discussion Question 1 Correct Answer: C. Send tissue for MLH-1, and MSH-2 and 6 staining. Main Histologic Features: • Dermal neoplasm with sebaceous differentiation throughout the tumor • Significant mitotic activity with atypical mitoses • No peripheral palisading or peritumoral mucin • Incidental overlying squamous cell carcinoma in situ Differential Diagnosis: • Basal cell carcinoma with sebaceous differentiation • Sebaceoma • Trichilemmal carcinoma • Granular cell tumor Clinical Concerns: • Facial neoplasms can be associated with systemic syndromes: Fibrofolliculomas/trichodiscomas seen in Birt-Hogg-Dubé syndrome 80-90% risk of pulmonary cysts 15-20% risk of renal cancer, particularly oncocytoma Trichilemmomas seen in Cowden syndrome Thyroid involved in 66% of cases Malignancy develops in at least 40% of patients. • Sebaceous neoplasms can be seen in Muir-Torre syndrome (MTS) which carries an increased risk of colon, genitourinary, breast and hematologic malignancies. • MTS is more commonly associated with extraocular sebaceous carcinomas. • MTS can be screened for by using immunohistochemical tissue stains for MLH-1, MSH-2 and MSH-6 proteins (Muir-Torre panel). Absence of staining identifies tumors with mismatch repair deficiency and suggests MTS, which can then be confirmed by genetic testing. References: • Ansai S, Takeichi H, Arase S, Kawana S, Kimura T.
    [Show full text]
  • Renal Oncocytoma with Invasive Histopathologic Features – Case Report
    CASE REPORT Renal Oncocytoma with Invasive Histopathologic Features – Case Report Renálny onkocytóm s histologickými črtami invázie – kazuistika Kolníková G.1, Marinová P.1, Gál V.1, Mečiarová I.1, Mišanko V.2, Rampalová J.1, Jáni P.1, Orthová S.1, Ondriaš F.1, Caňo M.2 1 Division of Pathology, Alpha Medical Patologia l.t.d., Bratislava- Ružinov, Slovak Republic 2 Department of Urology, University Hospital Bratislava- Ružinov, Slovak Republic Summary Background: Renal oncocytoma is an uncommon tumor, classifi ed as a benign renal neoplasm Autoři deklarují, že v souvislosti s předmětem in the World Health Organisation classifi cation of renal tumours. Despite it there were descri- studie nemají žádné komerční zájmy. bed several reports with invasive histopathologic features. Case report: We describe a case of The authors declare they have no potential renal oncocytoma with bizzare cells and invasion of renal sinus fat tissue. We performed immu- confl icts of interest concerning drugs, products, nohistochemical analysis of the case and a review of relevant literature. Conclusion: In order to or services used in the study. set up the right dia gnosis the perfect co- operation of clinicians and pathologists is necessary. Redakční rada potvrzuje, že rukopis práce In our opinion, in accordance with other authors, the renal oncocytomas should be considered splnil ICMJE kritéria pro publikace zasílané do bi omedicínských časopisů. as having a very low rather than no malignant potential, in spite of clinically benign behavior, supplementing a hypothesis, whether renal oncocytomas may be considered as a precance- The Editorial Board declares that the manuscript met the ICMJE “uniform requirements” for rous lesion of chromophobe carcinoma.
    [Show full text]
  • Immunohistochemical Analysis of Chromophobe Renal Cell Carcinoma, Renal Oncocytoma, and Clear Cell Carcinoma an Optimal and Practical Panel for Differential Diagnosis
    Immunohistochemical Analysis of Chromophobe Renal Cell Carcinoma, Renal Oncocytoma, and Clear Cell Carcinoma An Optimal and Practical Panel for Differential Diagnosis Lina Liu, MD; Junqi Qian, MD; Harpreet Singh, MS; Isabelle Meiers, MD; Xiaoge Zhou, MD; David G. Bostwick, MD ● Context.—The separation of chromophobe renal cell car- Cytokeratin 7 was positive in 18 (86%) of 22 cases of chro- cinoma, oncocytoma, and clear cell renal cell carcinoma mophobe carcinoma, whereas all oncocytomas were neg- using light microscopy remains problematic in some cases. ative for CK7. EpCAM protein was expressed in all 22 cases Objective.—To determine a practical immunohisto- of chromophobe carcinoma in more than 90% of cells, chemical panel for the differential diagnosis of chromo- whereas all EpCAM-positive oncocytomas (5/17; 29%) dis- phobe carcinoma. played positivity in single cells or small cell clusters. Design.—Vimentin, glutathione S-transferase ␣ (GST-␣), Conclusions.—Using the combination of 3 markers (vi- CD10, CD117, cytokeratin (CK) 7, and epithelial cell ad- mentin, GST-␣, and EpCAM), we achieved 100% sensitivity hesion molecule (EpCAM) were investigated in 22 cases of and 100% specificity for the differential diagnosis of chro- chromophobe carcinoma, 17 cases of oncocytoma, and 45 mophobe carcinoma, oncocytoma, and clear cell carcino- cases of clear cell carcinoma. ma. The pattern of ‘‘vimentinϪ/GST-␣Ϫ’’ effectively exclud- Results.—Vimentin and GST-␣ expression were exclu- ed clear cell carcinoma, and homogeneous EpCAM ex- sively observed in clear cell carcinoma. CD10 staining was pression confirmed the diagnosis of chromophobe carci- more frequently detected in clear cell carcinoma (91%) noma rather than oncocytoma. CD117 and CK7 were also than in chromophobe carcinoma (45%) and oncocytoma useful markers and could be used as second-line markers (29%).
    [Show full text]
  • Modern Pathology
    VOLUME 32 | SUPPLEMENT 2 | MARCH 2019 MODERN PATHOLOGY 2019 ABSTRACTS GENITOURINARY PATHOLOGY (INCLUDING RENAL TUMORS) (776-992) MARCH 16-21, 2019 PLATF OR M & 2 01 9 ABSTRACTS P OSTER PRESENTATI ONS EDUCATI ON C O M MITTEE Jason L. Hornick , C h air Ja mes R. Cook R h o n d a K. Y a nti s s, Chair, Abstract Revie w Board S ar a h M. Dr y and Assign ment Co m mittee Willi a m C. F a q ui n Laura W. La mps , Chair, C ME Subco m mittee C ar ol F. F ar v er St e v e n D. Billi n g s , Interactive Microscopy Subco m mittee Y uri F e d ori w Shree G. Shar ma , Infor matics Subco m mittee Meera R. Ha meed R aj a R. S e et h al a , Short Course Coordinator Mi c h ell e S. Hir s c h Il a n W ei nr e b , Subco m mittee for Unique Live Course Offerings Laksh mi Priya Kunju D a vi d B. K a mi n s k y ( Ex- Of ici o) A n n a M ari e M ulli g a n Aleodor ( Doru) Andea Ri s h P ai Zubair Baloch Vi nita Parkas h Olca Bast urk A nil P ar w a ni Gregory R. Bean , Pat h ol o gist-i n- Trai ni n g D e e p a P atil D a ni el J.
    [Show full text]
  • Genitourinary PAX8
    174A ANNUAL MEETING ABSTRACTS RMC and 19/21 (90%) of CDC cases. In contrast, 31/34 (91%) UUC were negative for Genitourinary PAX8. p63: p63 was positive in 7/12 (58%) RMC and in 3/21 (14%) CDC. Staining was focal in 6/7 RMC and strong in 4/7. Almost all (97%) UUC were p63 positive 767 Histopathologic Features of Bilateral Renal Cell Carcinomas: A (moderate/strong and multifocal/diffuse in 80% of cases). The one p63 negative UUC Study of 24 Cases was a microinvasive high grade tumor and was also negative for PAX8. J Abdelsayed, JY Ro, LD Truong, AG Ayala, SS Shen. The Methodist Hospital and Weill Conclusions: We suggest a binary panel of PAX8 and p63 as an aid in the differential Medical College of Cornell University, Houston, TX. diagnosis of high grade renal sinus epithelial neoplasms. (PAX8+/p63+) profile Background: The incidence of bilateral renal cell carcinoma (bRCC) has been reported supported the dx of RMC with a sensitivity of 58.3% and specificity of 89%. (PAX8+/ to vary from 1.5% to 11%. Clear understanding of the clinicopathologic features of p63-) profile supported the diagnosis of CDC with a sensitivity of 85.7% and a specificity bRCCs including the distinction between synchronous and metachronous tumors has of 89%. Finally (PAX8-/p63+) profile supported the diagnosis of UUC with a sensitivity important implications in patients’ management and follow up. The purpose of this study of 88% and a specificity of 100%. The concomitant expression of p63 and PAX8 in RMC is to summarize the clinicopathologic features of bRCCs and compare them with those seen in our study further suggests an intermediate phenotype between renal tubular and of unilateral renal cell carcinomas (uRCCs).
    [Show full text]
  • A Novel Marker of Kidney Neoplasia
    STUDY Birt-Hogg-Dube´ Syndrome A Novel Marker of Kidney Neoplasia Jorge R. Toro, MD; Gladys Glenn, MD, PhD; Paul Duray, MD; Thomas Darling, MD, PhD; Gregor Weirich, MD; Berton Zbar, MD; Marston Linehan, MD; Maria L. Turner, MD Background: Birt-Hogg-Dube´ syndrome (BHD) is a had a variant of papillary renal cell carcinoma. Thirteen dominantly inherited predisposition for development of patients exhibited BHD. Seven individuals, including a fibrofolliculomas, trichodiscomas, and acrochordons. set of identical twins, had renal neoplasms and BHD. An Concurrent internal tumors, such as colonic polyps and additional 4 patients (3 deceased and not examined) in renal carcinoma, have been described in patients with these families had renal neoplasms but not BHD. Birt- BHD. Hogg-Dube´ syndrome without renal neoplasms was pres- ent in 6 individuals. Thirteen patients with fibrofollicu- Objective: To evaluate kindreds with familial renal tu- lomas and trichodiscomas presented clinically with mors for cutaneous manifestations of BHD. multiple smooth skin-colored to grayish-white papules located on the face, auricles, neck, and upper trunk. Oral Design: One hundred fifty-two patients from 49 fami- papules were present in 9 of 28 and achrochordons in lies underwent complete oral and skin examination. Skin 11 of 28 patients. Features of BHD not previously ap- lesions were identified by their clinical appearance, and preciated included deforming lipomas in 5, collageno- the diagnosis was confirmed by results of histologic ex- mas in 4, and pulmonary cysts in 4 of 28 patients. Fami- amination. Individuals underwent screening for famil- lies with BHD did not display germline mutations in the ial renal neoplasms.
    [Show full text]